Hinrich Abken

Robert Koch Str. 21
Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

In vivo CAR T cells on the highway: a roadmap for the next decade.

In vivo CAR T cells on the highway: a roadmap for the next decade.

Journal: Expert opinion on biological therapy

Published: August 21, 2026

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

Journal: Human gene therapy

Published: June 18, 2026

Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of Gluconate.

Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of Gluconate.

Journal: Pharmaceutics

Published: April 02, 2026

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

Journal: Human gene therapy

Published: March 28, 2026

Augmenting CAR T cell functionality and metabolism through CD39 downtuning.

Augmenting CAR T cell functionality and metabolism through CD39 downtuning.

Journal: Molecular therapy. Oncology

Published: January 07, 2026

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma.

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma.

Journal: Frontiers in immunology

Published: October 15, 2025

Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas.

Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: September 05, 2025

Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction.

Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction.

Journal: Journal of translational medicine

Published: August 18, 2025

CAR T cells in solid tumors: resistance mechanisms

CAR T cells in solid tumors: resistance mechanisms

Journal: Innere Medizin (Heidelberg, Germany)

Published: June 17, 2025

CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

Journal: International journal of molecular sciences

Published: June 10, 2025

Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion.

Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion.

Journal: Cells

Published: May 05, 2025

Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.

Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.

Journal: Molecular therapy. Oncology

Published: April 22, 2025

Showing 1-12 of 137

Last Updated: 09/26/2026